2. 2Q10 Earnings Release
Highlights For The Period
• The company’s net profit increased 47.1% in relation to the previous quarter, reaching R$ 11.4 million representing
a net margin of 1.9%;
• A reduction of the inventory level in 11.2 days when compared to the 1Q10, reaching R$ 278.9 million or 45 days;
• A positive cash operating generation of R$ 47.4 million or 7.8% of the net operating revenue;
• A reduction of the relation, net debt / ebitda of the company in 6.7%, reaching 1.4x, leaving behind a position of 1.5x
in the previous quarter;
• A reduction of 42.4% of the EPM (errors per million of delivered units) dropping from 210.0 registered in the 1Q10 to
121.0 in the 2Q10;
• The sales volume through electronic orders beats the record and reaches 63,5% of the total of the sales in this
quarter.
2
6. 2Q10 Earnings Release
Gross Profit and Revenues from Services to Suppliers
(R$ million and as % Net Revenues)
13.4%
12.3%
10.4%
3.7
25.1
20.0
82.9
49.7
46.5
2Q09 1Q10 2Q10
Gross Profit Revenues from Services to Suppliers Gross Profit Margin (%)
6
7. 2Q10 Earnings Release
Operating Expenses
(R$ million and as % Net Revenues )
8.9%
7.7% 7.5%
53.8
49.9 48.1
2Q09 1Q10 2Q10
7
8. 2Q10 Earnings Release
Net Financial Expenses
(R$ million and as % Net Revenues)
1.9%
1.3%
0.8%
11.8
8.5
5.4
2Q09 1Q10 2Q10
8
9. 2Q10 Earnings Release
Net Profit
(R$ million and as % Net Revenues)
2.8%
1.9%
1.2%
17.9
11.4
7.8
2Q09 1Q10 2Q10
9
10. 2Q10 Earnings Release
Ebitda and Ebitda Margin
(R$ million and as % Net Revenues)
5.8%
3.6%
2.8%
37.8
21.8
17.9
2Q09 1Q10 2Q10
10
18. IR Contacts
Max Fischer
CFO and IR Director
Beatriz Diez
IR Manager
Telephone.: 55 (21) 4009 0276
E-mail: ri@profarma.com.br
www.profarma.com.br/ir
